The molecular mechanism underlying its overexpression in pancreatic carcinomas is based on the presence of cis-acting AREs in the PIM1’s mRNA 3′ untranslated region, which mediates an interaction with HuR in a tumor hypoxia context [41]. This evidence concerns the gene ELAVL1 and neoplasm.